Abstract
Aim:
Recent experimental and human studies have shown that hyperuricemia is associated with hypertension and cardiovascular diseases. Elevated levels of endothelin-1 (ET-1) has been regarded as one of the most powerful independent predictors of cardiovascular diseases. For investigating whether uric acid-induced vascular diseases are related to ET-1, the uric acid-induced ET-1 expression in human aortic smooth muscle cells (HASMC) was examined.
Methods:
Cultured HASMC treated with uric acid, cell proliferation and ET-1 expression were examined. Antioxidant pretreatments on uric acid-induced extracellular signal-regulated kinases (ERK) phosphorylation were carried out to elucidate the redox-sensitive pathway in proliferation and ET-1 gene expression.
Results:
Uric acid was found to increase HASMC proliferation, ET-1 expression and reactive oxygen species production. The ability of both N-acetylcysteine and apo-cynin (l-[4-hydroxy-3-methoxyphenyl]ethanone, a NADPH oxidase inhibitor) to inhibit uric acid-induced ET-1 secretion and cell proliferation suggested the involvement of intracellular redox pathways. Furthermore, apocynin, and p47phox small interfering RNA knockdown inhibited ET-1 secretion and cell proliferation induced by uric acid. Inhibition of ERK by U0126 (1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene) significantly suppressed uric acid-induced ET-1 expression, implicating this pathway in the response to uric acid. In addition, uric acid increased the transcription factor activator protein-1 (AP-1) mediated reporter activity, as well as the ERK phosphorylation. Mutational analysis of the ET-1 gene promoter showed that the AP-1 binding site was an important cis-element in uric acid-induced ET-1 gene expression.
Conclusion:
This is the first observation of ET-1 regulation by uric acid in HASMC, which implicates the important role of uric acid in the vascular changes associated with hypertension and vascular diseases.
Similar content being viewed by others
Article PDF
References
Feig DI, Kang DH, Nakagawa T, Mazzali M, Johnson RJ . Uric acid and hypertension. Curr Hypertens Rep 2006; 8: 111–5.
Gertzberg N, Neumann P, Rizzo V, Johnson A . NAD(P)H oxidase mediates the endothelial barrier dysfunction induced by TNF-alpha. Am J Physiol Lung Cell Mol Physiol 2004; 286: L37–48.
Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, et al. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006; 8: 691–728.
Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38: 1101–6.
Watanabe S, Kang DH, Feng L, Nakagawa T, Kanellis J, Lan H, et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 2002; 40: 355–60.
Itoh H, Higuchi H, Hiraoka N, Ito M, Konishi T, Nakano T, et al. Contraction of rat thoracic aorta strips by endothelin-1 in the absence of extracellular Ca2+. BrJ Pharmacol 1991; 104: 847–52.
Cai L, Kang YJ . Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovase Toxicol 2001; 1: 181–93.
Sautin YY, Nakagawa T, Zharikov S, Johnson RJ . Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007; 293: C584–96.
Iglarz M, Schiffrin EL . Role of endothelin-1 in hypertension. Curr Hypertens Rep 2003; 5: 144–8.
Ergul A . Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents. Pharmacotherapy 2002; 22: 54–65.
Suzuki S, Wenyi Z, Hirai M, Hinokio Y, Suzuki C, Yamada T, et al. Genetic variations at urotensin II and urotensin II receptor genes and risk of type 2 diabetes mellitus in Japanese. Peptides 2004; 25: 1803–8.
Hong HJ, Chan P, Liu JC, Juan SH, Huang MT, Lin JG, et al. Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells. Cardiovasc Res 2004; 61: 159–68.
Cheng TH, Shih NL, Chen SY, Loh SH, Cheng PY, Tsai CS, et al. Reactive oxygen species mediate cyclic strain-induced endothelin-1 gene expression via Ras/Raf extracellular signal-regulated kinase pathway in endothelial cells. J Mol Cell Cardiol 2001; 33: 1805–14.
Wung BS, Cheng JJ, Hsieh HJ, Shyy YJ, Wang DL . Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein 1. Circ Res 1997; 81: 1–7.
Cheng JJ, Chao YJ, Wang DL . Cyclic strain activates redox-sensitive proline-rich tyrosine kinase 2 (PYK2) in endothelial cells. J Biol Chem 2002; 277: 48152–7.
Chen CH, Cheng TH, Lin H, Shih NL, Chen YL, Chen YS, et al. Reactive oxygen species generation is involved in epidermal growth factor receptor transactivation through the transient oxidization of Src homology 2-containing tyrosine phosphatase in endothelin-1 signaling pathway in rat cardiac fibroblasts. Mol Pharmacol 2006; 69: 1347–55.
Cheng TH, Shih NL, Chen SY, Wang DL, Chen JJ . Reactive oxygen species modulate endothelin-I-induced c-fos gene expression in cardiomyocytes. Cardiovasc Res 1999; 41: 654–62.
Miyazaki H, Sekine T, Endou H . The multispecific organic anion transporter family: properties and pharmacological significance. Trends Pharmacol Sci 2004; 25: 654–62.
Bedard K, Krause KH . The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007; 87: 245–313.
Kawana M, Lee ME, Quertermous EE, Quertermous T . Cooperative interaction of GATA-2 and API regulates transcription of the endothelin-1 gene. Mol Cell Biol 1995; 15: 4225–31.
Cheng TH, Cheng PY, Shih NL, Chen IB, Wang DL, Chen JJ . Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J Am Coll Cardiol 2003; 42: 1845–54.
Feig DI, Johnson RJ . Hyperuricemia in childhood primary hypertension. Hypertension 2003; 42: 247–52.
Cannon RO 3rd . Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clin Chem 1998; 44: 1809–19.
Grote K, Ortmann M, Salguero G, Doerries C, Landmesser U, Luchtefeld M, et al. Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation. Cardiovasc Res 2006; 71: 596–605.
Cai H, Griendling KK, Harrison DG . The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 2003; 24: 471–8.
Keaney JF Jr . Oxidative stress and the vascular wall: NADPH oxidases take center stage. Circulation 2005; 112: 2585–8.
Lavigne MC, Malech HL, Holland SM, Leto TL . Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells. Circulation 2001; 104: 79–84.
Cheng CM, Hong HJ, Liu JC, Shih NL, Juan SH, Loh SH, et al. Crucial role of extracellular signal-regulated kinase pathway in reactive oxygen species-mediated endothelin-1 gene expression induced by endothelin-1 in rat cardiac fibroblasts. Mol Pharmacol 2003; 63: 1002–11.
Touyz RM, Yao G, Schiffrin EL . c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vase Biol 2003; 23: 981–7.
Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, et al. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 2002; 90: 1205–13.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chao, Hh., Liu, Jc., Lin, Jw. et al. Uric acid stimulates endothelin-1 gene expression associated with NADPH oxidase in human aortic smooth muscle cells. Acta Pharmacol Sin 29, 1301–1312 (2008). https://doi.org/10.1111/j.1745-7254.2008.00877.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2008.00877.x
Keywords
This article is cited by
-
Hyperuricemia and diabetes mellitus when occurred together have higher risks than alone on all-cause mortality and end-stage renal disease in patients with chronic kidney disease
BMC Nephrology (2022)
-
Lung function decline is associated with serum uric acid in Korean health screening individuals
Scientific Reports (2021)
-
Uric acid and cardiometabolic diseases
Clinical Hypertension (2020)
-
Sodium butyrate recovers high-fat diet-fed female Wistar rats from glucose dysmetabolism and uric acid-associated cardiac tissue damage
Naunyn-Schmiedeberg's Archives of Pharmacology (2019)
-
Uric acid causes kidney injury through inducing fibroblast expansion, Endothelin-1 expression, and inflammation
BMC Nephrology (2017)